Lin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lin Wu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Binxun Li
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei, People's Republic of China
1 shared publication - Dongdong Zhao
Tongji Univ, Shanghai Peoples Hosp 10, Dept Cardiol, Sch Med, 301 Yanchang Rd, Shanghai 200072, Peoples R China
1 shared publication - Hong Jiang
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
1 shared publication - Hua Ye
Department of Burns & Plastic and Wound Repair, Ganzhou People’s Hospital, Ganzhou, China
1 shared publication Jiajin Tu
Department of Burns & Plastic and Wound Repair, Ganzhou People’s Hospital, Ganzhou, China
1 shared publicationRunyang Feng
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by Springer Nature in Molecular Medicine
- Vol. 32 (1)
Targeting DNA damage signaling in atherosclerosis: molecular mechanisms and therapeutic opportunities
- 27 August 2026
- Published by Springer Nature in Molecular Medicine
- Vol. 32 (1)
Open AccessTargeting DNA damage signaling in atherosclerosis: molecular mechanisms and therapeutic opportunities
- Open Access
- 8 July 2019
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 16 (1) , 1-10
Light-emitting diode therapy protects against ventricular arrhythmias by neuro-immune modulation in myocardial ischemia and reperfusion rat model
Sympathetic overactivation and inflammation are two major mediators to post-myocardial ischemia-reperfusion (I/R)-induced ventricular arrhythmia (VA). The vicious cycle between microglia and sympathetic activation plays an important role in sympathetic hyperactivity related to cardiovascular diseases. Recently, studies have shown that microglial activation might be attenuated by light-emitting diode (LED) therapy. Therefore, we hypothesized that LED therapy might protect against myocardial I/R-induced VAs by attenuating microglial and sympathetic activation. Thirty-six male anesthetized rats were randomized into four groups: control group (n = 6), LED group (n = 6), I/R group (n = 12), and LED+I/R group (n = 12). I/R was generated by left anterior descending artery occlusion for 30 min followed by 3 h reperfusion. ECG and left stellate ganglion (LSG) neural activity were recorded continuously. After 3 h reperfusion, a programmed stimulation protocol was conducted to test the inducibility of VA. Furthermore, we extracted the brain tissue to examine the microglial activation, and the peri-ischemic myocardium to examine the expression of NGF and inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α). As compared to the I/R group, LED illumination significantly inhibited the LSG neural activity (P < 0.01) and reduced the inducibility of VAs (arrhythmia score 4.417 ± 0.358 vs. 3 ± 0.3257, P < 0.01) in the LED+I/R group. Furthermore, LED significantly attenuated microglial activation and downregulated the expression of inflammatory cytokines and NGF in the peri-infarct myocardium. LED therapy may protect against myocardial I/R-induced VAs by central and peripheral neuro-immune regulation.
- 8 July 2019
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 16 (1) , 1-10
Open AccessLight-emitting diode therapy protects against ventricular arrhythmias by neuro-immune modulation in myocardial ischemia and reperfusion rat model
Sympathetic overactivation and inflammation are two major mediators to post-myocardial ischemia-reperfusion (I/R)-induced ventricular arrhythmia (VA). The vicious cycle between microglia and sympathetic activation plays an important role in sympathetic hyperactivity related to cardiovascular diseases. Recently, studies have shown that microglial activation might be attenuated by light-emitting diode (LED) therapy. Therefore, we hypothesized that LED therapy might protect against myocardial I/R-induced VAs by attenuating microglial and sympathetic activation. Thirty-six male anesthetized rats were randomized into four groups: control group (n = 6), LED group (n = 6), I/R group (n = 12), and LED+I/R group (n = 12). I/R was generated by left anterior descending artery occlusion for 30 min followed by 3 h reperfusion. ECG and left stellate ganglion (LSG) neural activity were recorded continuously. After 3 h reperfusion, a programmed stimulation protocol was conducted to test the inducibility of VA. Furthermore, we extracted the brain tissue to examine the microglial activation, and the peri-ischemic myocardium to examine the expression of NGF and inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α). As compared to the I/R group, LED illumination significantly inhibited the LSG neural activity (P < 0.01) and reduced the inducibility of VAs (arrhythmia score 4.417 ± 0.358 vs. 3 ± 0.3257, P < 0.01) in the LED+I/R group. Furthermore, LED significantly attenuated microglial activation and downregulated the expression of inflammatory cytokines and NGF in the peri-infarct myocardium. LED therapy may protect against myocardial I/R-induced VAs by central and peripheral neuro-immune regulation.